Shah Nissar A, Antoine Heath J, Pall Marita, Taylor Kent D, Azziz Ricardo, Goodarzi Mark O
Division of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.
J Clin Endocrinol Metab. 2008 May;93(5):1939-45. doi: 10.1210/jc.2008-0038. Epub 2008 Feb 26.
Genetically determined heightened androgen sensitivity may influence the phenotype of polycystic ovary syndrome (PCOS). To date, studies of the androgen receptor exon 1 polymorphic CAG repeat have produced conflicting results in PCOS.
We tested the hypothesis that a lower number of CAG repeats is associated with increased odds of PCOS. We also compared X-chromosome inactivation between cases and controls.
Women with and without PCOS were genotyped for the CAG repeat and assessed for X-chromosome methylation. Association analyses were performed.
Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; controls were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles.
Participants included 330 women with PCOS and 289 controls (77% white, 23% black).
Androgen receptor genotype, X-chromosome methylation, and phenotyping for PCOS were measured.
A smaller biallelic mean of CAG repeats was associated with increased odds of PCOS. X-chromosome inactivation was not different comparing cases with controls; however, in the subset with nonrandom inactivation, the chromosome bearing the shorter CAG allele was preferentially active in PCOS women.
Association of shorter CAG repeats with PCOS is consistent with in vitro functional studies demonstrating higher activity of androgen receptors expressed from alleles with fewer CAG repeats, suggesting inherited alteration in androgen sensitivity may contribute to PCOS. In some women, such heightened sensitivity may also result from preferential expression of androgen receptors with shorter alleles. Thus, genetic and epigenetic changes may be involved in the pathogenesis of PCOS.
基因决定的雄激素敏感性增强可能会影响多囊卵巢综合征(PCOS)的表型。迄今为止,关于雄激素受体外显子1多态性CAG重复序列的研究在PCOS患者中得出了相互矛盾的结果。
我们检验了以下假设,即CAG重复序列数量较少与PCOS患病几率增加相关。我们还比较了病例组和对照组之间的X染色体失活情况。
对患有和未患有PCOS的女性进行CAG重复序列基因分型,并评估其X染色体甲基化情况。进行了关联性分析。
研究对象从阿拉巴马大学伯明翰分校生殖内分泌诊所招募;对照组从周边社区招募。基因分型在洛杉矶的雪松西奈医疗中心进行。
参与者包括330名患有PCOS的女性和289名对照组女性(77%为白人,23%为黑人)。
测量了雄激素受体基因型、X染色体甲基化以及PCOS的表型。
CAG重复序列的双等位基因平均数量较少与PCOS患病几率增加相关。病例组和对照组的X染色体失活情况没有差异;然而,在非随机失活的亚组中,携带较短CAG等位基因的染色体在PCOS女性中优先激活。
较短的CAG重复序列与PCOS的关联与体外功能研究一致,该研究表明CAG重复序列较少的等位基因所表达的雄激素受体具有更高的活性,这表明雄激素敏感性的遗传改变可能导致PCOS。在一些女性中,这种增强的敏感性也可能源于较短等位基因的雄激素受体的优先表达。因此,基因和表观遗传变化可能参与了PCOS的发病机制。